These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15163309)

  • 1. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
    Botella-Carretero JI; Gómez-Bueno M; Barrios V; Caballero C; García-Robles R; Sancho J; Escobar-Morreale HF
    Endocr Relat Cancer; 2004 Jun; 11(2):345-56. PubMed ID: 15163309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
    Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
    Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
    Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
    Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term overt hypothyroidism induces discrete diastolic dysfunction in patients treated for differentiated thyroid carcinoma.
    Hoftijzer HC; Bax JJ; Heemstra KA; Bleeker GB; Delgado V; van der Klaauw AA; Romijn JA; Smit JW; Corssmit EP
    Eur J Clin Invest; 2009 Mar; 39(3):204-10. PubMed ID: 19260950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thyroxine withdrawal in biochemical parameters and cardiac function and structure in patients with differentiated thyroid cancer.
    Chrisoulidou A; Pazaitou-Panayiotou K; Kaprara A; Platoyiannis D; Lafaras C; Boudina M; Georgiou E; Drimonitis A; Bischiniotis T; Vainas I
    Minerva Endocrinol; 2006 Jun; 31(2):173-8. PubMed ID: 16682940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal.
    Botella-Carretero JI; Prados A; Manzano L; Montero MT; Escribano L; Sancho J; Escobar-Morreale HF
    Eur J Endocrinol; 2005 Aug; 153(2):223-30. PubMed ID: 16061828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.
    Abdulrahman RM; Delgado V; Hoftijzer HC; Ng AC; Ewe SH; Marsan NA; Holman ER; Hovens GC; Corssmit EP; Romijn JA; Bax JJ; Smit JW
    Thyroid; 2011 May; 21(5):471-6. PubMed ID: 21417919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma.
    Botella-Carretero JI; Galán JM; Caballero C; Sancho J; Escobar-Morreale HF
    Endocr Relat Cancer; 2003 Dec; 10(4):601-10. PubMed ID: 14713270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
    Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
    Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thyroid hormones on serum levels of adipokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal.
    Botella-Carretero JI; Alvarez-Blasco F; Sancho J; Escobar-Morreale HF
    Thyroid; 2006 Apr; 16(4):397-402. PubMed ID: 16646687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free thyroid hormones and a third-generation TSH assay in the detection of hyperthyroidism during long-term thyroxine treatment in thyroid carcinoma patients.
    Taimela E; Koskinen P; Nuutila P; Nikkanen V; Saraste M; Taimela S; Irjala K
    Scand J Clin Lab Invest; 1995 Apr; 55(2):181-6. PubMed ID: 7667611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
    Gazdag A; Nagy EV; Erdei A; Bodor M; Berta E; Szabó Z; Jenei Z
    J Endocrinol Invest; 2015 Feb; 38(2):133-42. PubMed ID: 25194423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone turnover markers in patients with differentiated thyroid carcinoma after levothyroxine withdrawal.
    Gao YC; Gu Q; Liu QP; Ge WL; Lu HK
    Clin Lab; 2010; 56(3-4):87-93. PubMed ID: 20476639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].
    Zhou J; Du J; Ma B; Liu X; Qiu H; Li J; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):109-13. PubMed ID: 24739642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
    Papadakis G; Kalaitzidou S; Triantafillou E; Drosou A; Kakava K; Dogkas N; Pappa T; Kaltzidou V; Tertipi A; Villiotou V; Pappas A
    Anticancer Res; 2015 Dec; 35(12):6933-40. PubMed ID: 26637919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.
    Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N
    Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism.
    Price DE; O'Malley BP; Northover B; Rosenthal FD
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):67-9. PubMed ID: 1889141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.